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Summary 
Gum arabic has long been used In the beverage 
industry as an emulsifier and more recently, its 
potential 10 be used in microencapsulatioo technologies 
has been explored, with positive results. A mOdified 
gum arabic (Acacia (sen) SUPER GUM'''), marketed as 
SUPER GUM"', has recently become available on the 
market. SUPER GUM'" has been modified by an 
accelerated storage process, and is characterised by 
increased molecular weight and greater surface activity 
compared to unmodified gum arabic. In this work, we 
present two different applications of SUPER GUM'" as 
an encapsulating agent. The encapsulation efficiencies 
1, Introduction 
Microencapsulation technologies are currently being utilised 
in a wide range of industries such as food. cosmetics, 
pharmaceuticals and agrochemical. Many of the 
microencapsulation methods used in these industries involve 
the initial klnnation of an emulsion beiJre subsequent chemical 
fixing, spray drying or chill cooling. In all cases, the emulsifier 
used must possess superior emulsion forming and emulsion 
stabilising properties to emulsify the hydrophobic or oil phase, 
and to impart long·tenn stability to a product which may 
eventually be redispersed in an aqueous medium. A variety of 
materials have been studied exteosively as emulsifiers; proteins 
such as caseinateU, whey proteins!). soy protemsJ] and their 
hydrolysate$" · and polysaccharides such as pectin-, modified 
stan::h~ and gum arabic". Gum arabic has been extensively used 
as an encapsulating agent in a coacervate'\, as the sole 
emulsifier in bevenges-, and also as a mmponent in a spray-
dried miaoencapsulated system'0. A recent introductioo to the 
emulsifier market is a modified gum arabic, marketed as 
SUPER GUM"lN. SUPER GUM'"" is different from unmodified 
gum arabic. in that it has undergone an acceIer.tted aggregation 
process, the results of which are larger molecular wejghts and 
higher surface activity. The ph)'5icochemical chamcteristics of 
SUPER GUM"' have been well desaibed"-". In Ibis work, ""e 
describe the use of SUPER GUM'" as a microencapsulating 
agent in two different applications: stahle, high encapsulation 
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of multiple emulsions were increased following the use 
of SUPER GUM"' as an external emulsifier. A second 
applicalioo, for the microencapsulation of a proprietary 
anti-microbial dairy blend, Glovon, is also reported. 
Efficiency of the microencapsulation process was 
indicated by altered sensitivity against Staphylococcus 
aureus 9518. Hydration time and presence of bile salts 
also affected the anll-microbial activity of Glovon and 
microencapsulated Glovon differently, with 
microencapsulated Glovon retaining grealer activity 
than non-encapsulated Glovoo . 
efficiency multiple emulsions, and as a microencapsulating 
agent for a novel anlHnicrobial. 
Multiple emulsions are emulsion systems in which the 
dispersed phase is itsell an emulsion, and they have been 
extensively studied as a means of encapsu1ation17 .... However. 
despite their immense potential, the application of multiple 
emulsions in food systems has been limited by their inherent 
thermodynamic instability, which causes leakage of the 
encapsulant &urn the inner aqueous phase, flocculation of the 
droplets or phase separation during processing and stonge""-. 
Glovon is a natural dairy derived antHnicrobiai with efficacy 
against a range of microbes. It has been applied into a range of 
products, such as gels. hand washes. toothpaste and mouth 
sprays to aid with personal care and oral bygiene. Additionally, 
Glovon is being evaluated for its ability to act against intestinal 
tract pathogens in immune-compromised individuals. 
Colonisation by such intestinal tract. pathogens and subsequent 
infection occurs in response In destabilisation of the indigenous 
microflora usually by anti-biotic treatment in hospitalised 
patients. Recurrent infection or relapse following conventional 
(anti-biotic) treatment is • major problem with intestinailTad 
pathogen infection. Once in the small intestine, Giovoo may be 
able In successfully prevent opportunistic growth of pathogens. 
Howe"Yef", the components of Glovoc will have to be protected 
against acidic. enzymatic and complexing forces encountered 
on passing through the uwe' gastrointestinal tract 
2. Materials and Methods 
Conunercial soybean oil was purchased from AMCO Ltd., 
Auckland, New Zealand. Polyglycerol ester of polyricinoleic acid 
(PGPR 4150, Paisgaaro Ud .• Denmark) was purchased from 
Hawkins Watt Ltd, Auckland, New Zealand. Commercial 
sodium caseinate was obtained from Fonterra Cooperative l1d., 
PalmerslOO North, New Zealand, and contained approximately 
93% protein, 1.2% mum, and 0.06% calcitUtl. Vtelet dye poly 
R478 was purchased from Sigma l..td., San Louis. USA, and Nile 
Blue was from BDH Ud, Poole, UK Glovon and whey protein 
isolate (Provon 190, containing 9(}92% protein) was obtained 
from Glanhia Nutritiona1s, Kilkenny. Ireland. All microbioiogjca1 
medla was from Oxoid (BasingslDke. Hampshire. England) and 
Staphylococcus aureus 9518 s train was from the National 
Collections of Industrial Food and Marine Bacteria (NCIMB), 
Aberdeen. Scotland. SUPER GUM"" was kindly gifted from San-
Ei Gen F.F.I., Inc. Osaka, Japan. and contained approximately 
1.7% salt 
2-1. p~tion.r multiple ftnuhions 
Multiple emulsions were prepared by a two-step process with 
a two stage homogeniser (APV 2000, Denmark) with a slight 
modification to the method described previously·Q. For 
preparation of prinwy water..m."<)il (W /0) emulsions, 2% (w/v) 
of the hydrophobic emulsifier PGPR was initially mixed with 
soybean oil. Subsequently, the emulsifier/oil mixture was 
mixed in a 1:4 ratio with 0.1 M mum phosphate buffer at pH 
6.6. The aqueous phase contained either sodium caseinate 
(0.5% wlv) or varying concentrations of SUPER GUM"". In 
addition, the internal aqueous phase conlained a water soluble 
dye (Poly R-478) which allowed foe measurement of stability of 
the internal emulsion. The mixtures were homogenised at 
SOO/1Kl bar (first-stage pressure/second stage pressure) twice 
to oblain the primary W /0 emulsions. The second step ilMIfved 
the di~on of the primary emulsions into solutions (sodium 
caseinate, 0.5% w/v or SUPER. GUM"", o.2% w/v). prepared in 
0.1 M sodium phosphate buffer at pH 6.6. using the same 
homogeniser, at a pressure of 100/0 bar twice. The ratio of 
primary W /0 emulsion: buffer solution was 1:4. 
2·2. Charac:wlsatlon of multiple emulsions 
2-2-1. Conlocal laser rricroscopy 
Confocal scanning laser microscopy (CSLM) was used to 
observe the multiple emulsion samples (l..eica. TCS 4D confocal 
microscope, Lcica Lasertechnik GmbH, Heidelberg, Germany). 
Samples (1 mI) of emuJsions were stained with 0.1 ml of 1% 
(wt) Nile Blue, and the stained samples were dropped on 
concave glass slides. covered by cover slide and examined with 
a lOO X magnifications lens using an Ar/Kr laser with an 
excitation line of 488 nm; the resolution of this techniques is 
>02#m. 
2-2-2. Determination of average droplet size of multiple 
emulsions 
The droplet sizes of secondary emulsions were measured by 
a Malvern Mastersizer MSE (Ma1vern Instruments Ltd. 
Malvern, Worcestershire, United Kingdom). Volume average 
diameter (d..) and surface average diameter (d..) of multiple 
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emulsions were detennined. The lens range was set at 45 mm 
and the active beam length at 2.4 mm. 1be presentation code 
was 2NAD, the relative refractive index, Le. the ratio of the 
refractive index of emulsion droplets to that of the dispersion 
medium was 1.005 and the absorbance value of the emulsion 
droplets was 0.001. 
2·2-3_ Determination of encapsulation etliciency (EEl 
The EE is defined as the percentage of the water soluble dye 
(Poly R-478) retained inside the internal aqueous phase. 
measured immediately after multiple emulsion preparation and 
afterone month's stonIge at 2O"C'n• 
2-3. Prepantion of ~ Glovon 
A 10% (w/v) SUPER GUM"" solution was prepared. adjusted 
ID pH 7.0 and allowed ID hydrate fully overnight A 10% (w/v) 
whey protein isolate solution was also prepared, pH unadjusted. 
(PH 6.7) and allowed to hydrate overnight The foUowing day, a 
25% oil emulsion was prepared using SUPER GUM"" as the 
emulsifier and Glovon's proprietruy blend of fatty acids as the oil 
phase. The pre-emulsion was blended on a Silverson (UR 
Model. Chesham, HP5 IPQ, UK) for 2 mins at 4,500 rpm. 
Subsequently, the pre-emulsion was twice passed through a 
two-stage APV high pressure homogeniser (APV 1000, 
Albertslund, Denmark) at 450/50 bar (first-stage 
pressure/second stage pressure). Care was taken to prevent 
unhomogeoised material and semi-homogenised material 
coming into contact with th@final product. Fifteen minutes after 
emulsion formation, the emulsion was mixed 9 parts to t with 
the 10% WPI solution. The emuIsion-WPI mi:mu-e was frozen at 
- 8O"C until fully frozen. Samples were subsequently 
Iyophilised using a rreezone 4.5 lab-scale freeze dyer 
(labconco. Kansas, MO) until a fine powder was obtained. 
2-4. Clw-acWrisation of mkfoencapw.lated Glovon (MEG) 
2-4-1. Assessing the antimicrobial activity of Gloven and 
MEG 
locreasing concentrations (o.l %) of both MEG and Gloven 
were resuspended in diluted overnight SUphylocrxx:us aureus 
9518 culture. 100 p.1 aliquots were taken at time O. 3. 10, 30 and 
00 nUn, serially diluted. and spread plated on Tryptic Soya agar 
(fSA) plates. Plates were iooJ.bated at 37'C for 24 hours and the 
resulting colonies counted. 
2-4-2. Effect of hydration on Glovoo and MEG 
To determine the effect of hydration on Glovon and MEG the 
above experiment was repeated with the followi.ng modification: 
prior to commencing the experiment Gloven and MEG were 
hydrated in Tryptic soya broth (fSB) for 1 hour. T"unepoints 
were taken at 0, 10.30 and 60 min. 
2--4-3. Effect of 5~ and 7.5~ bile salts on GIoYon and MEG 
To detennine the effect of bile salts on Gloven and MEG. 1% 
Glovon and 1% MEG were resuspended in dilute overnight 
9518 culture containing either 5% or 7.5% bile salts, mixed and 
the stopwatch started. Controls included (a) broth cootaining 
just culture (b) broth containing cultuNl and 5% bile salts and 
(c) broth coota:ini.ng culture and 7.5% bile salts.. 100 p.1 a1iquots 
were taken at time 0, 10, 30 and 60 min, serially diluted and 
spreacipiated on Tryptic Soya agar ([SA) plates. Plates were 
incubated at 37'"C for 24 houf5 and the resulting colonies 
counted. 
2-4-4. Sirrulated gastric juice studies 
A 10% resuspension of MEG and Glovon were added to an 
equal volume of simulated gastri; juice (at pH Z) and inaJbated at 
37'C for 2 hours. Samples were taken at time 0 and at regular 
intervals up to l20 min. The pH values of the samples were 
adjusted to pH 1 prior to assaying and activity was determined 
by the agar well diffusioo assay with Uctococcus Jsctjs HP as 
the indicator strain. 
2-4·5. SlmtJ.ated ileum juice studies 
A 10% resuspension of MEG and Glovon were added to an 
equal volume of simulated ileum juice (pH 7) and incubated at 
37'C for 5 houn. Samples were taken at time 0 and regular 
intervals thereafter up to 5 h. Antimicrobial activity was 
detennined by the agar weII diffusion assay with UJctobadlJus 
gasseri as the indicator strain. 
2·4-6. SImulated colon juice studies 
A 10% resuspension of MEG and Glovon were added to an 
equal voIwne of simulated cob!;rice (pH 7) and inrubated at 37'"C 
for 24 hours. Samples were taken at time 0 and at intervals 
(., 
(b) 
(<l 
Figure 1. Confocal miaosoopy Images of mu~8 emulsions with 
2% (w/v) PGPR In olt phase, O.5~ (w/V) sodium 
caseInate in external aqueous phase and varying 
concentration 01 SUPER GUM"" In the Internal aQUeous 
phase. a: O~, b: 2~, c: 8~ (wN). 5cale bar repfesanls 
SJl.m. 
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thereafter up to 24 h. Antimicrobial activity was detenninecl by 
the agar well diffusion assay with LactobacilJus gasseri as the 
indicator strain. 
3. Results and Discussion 
3-1. FlT«t of addition of SUPER GUM'" to tho! InwrnaJ *lUftUS 
pbUO! of multiplO! emulsions 
The presence of multiple emulsioo oil droplets (containing 
0.5% (wlv) sodium caseinate in the extemal aqueous phase) 
was confirmed by ronfocai mittoscopy (FIgUre 1). The addition 
nf SUPER GUM"" to the internal aqueous phase of these 
systems did not resu1t in observable changes to the appearance 
of the multiple emulsion droplets. However, some unsoluble 
material was evident in SUPER GUM'" solutions prepared in 
the sodium phosphate buffer. 
The droplet size distributions of multiple em.!lsions prepared 
with SUPER GUM""" in the internal aqueous phase are 
presented in Figure 2a. Droplet size distributions nf all 
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Figure 2. Particle size disbibulions (al and yield! (b) of multiple 
emulsions prepared with 2:J1i (w/v) PGPR in 011 phase, 
0.5" (w/v) sodium caseinate in the external aqueous 
phase and varying (1-10% w/v) SUPER GUM"" 
concentrations in the int8fnat aqueous phase. Control 
sample had 0.5% (w/V) sodium caseinate in the internal 
aqueous phase. Blank bar: day 0; Dotted bar: one week 
SIOtap8 allOt: . 
emulsions exhibited a bimodal distribution, typical of all 
multiple emulsions prepared under the curreot set of conditions 
and were similar til the control emulsion prepared with 0.5% 
sodium caseinate in the internal aqueous phase. 
The encapsulation efficiencies (EE) of multiple emulsions 
prepared with varying SUPER GU~ concentrations (1 to 10% 
w/ v) in the internal aqueous phase were detennined (Figure 
2b) . Overall, signi6cantly increased EE of multiple emulsion 
were obtained after the addition of SUPER GUMr .. to the 
internal aqueous phase, at all concentrations of SUPER GUM'"" 
examined, compared to the yields of emulsion prepared without 
SUPER GUM'" in the internal aqueous phase. 
3·2. Effeet of Mldition of SUPER GUM'" to the extema! ~ueous 
phne of multiple emulsions 
The external aqueous phase of the multiple emulsions 
containing 0.125--2% (w/v) SUPER GUM"' were analysed by 
confocal microscopy (results not shown). The presence of 
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Figure 3. EffQCt of SUPER GUM'~ COI"Icenlration In lI1e external 
aqueous phase on lI1e particle size dstributions (a) and 
yields (b) of multiple emulsions (prepared with 2~ (wi'l) 
PGPR in oil phase and 0.5'6 (wi'l) sodium caseinate In 
Ina inl8mat aqueous phase). Control sarJ1)Ie had 0.5% 
(wi'll Sodium caseinate in ltIe exlernal aqueous ptlase. 
Blank bar: day 0; DoII&d bar: one _eI< storage at20t . 
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coalesa!d and Ilocculated oil droplets in the multiple emulsion 
prepared at low concentrations of SUPER GUM'" (0.125-0.5%) 
were detected, while flocculation was less evident in multiple 
emulsions prepared with;t 1% (w/v) SUPER GUM"" in the 
external aqueous phase. Again. some insoluble material was 
observed in the emulsion sample. 
TIle droplet siu distributions of multiple emulsions prepared 
with SUPER GUM .... in the external aqueous phase are 
presented in Figure 3a. Droplet size distributions of all 
emulsions again exhibited a typical bimodal distribution. and 
were similar to the control emulsion prepared with 0.5% 
90dium caseinate in the external aqueous phase. 
AI. 0.125-2% (w/v) SUPER GUMT'", lIOme of the oil droplets 
were outside the range of the Mastersizers range, indicating 
coalesced oil droplets of size greater than 50 Jl m (FIgUre 3a). 
'This result is in agreement with the conJQcal. microscoP'l image 
flocculation was not observed in multiple emulsi<.ns prepared 
with:. 2% (w/v) SUPER GUM'" in the external aqueous phase. 
The EEs of multiple emulsions prepared with v31)'ing SUPER 
GUM"" concentrations (0.125 to 2% w/v) in the external 
aqueous phase were determined (Figure 3b). Overall, the 
yields of multiple emulsions increased after the addition of 
SUPER GUM"" in the external aqueous phase, compared In the 
yields of emulsion prepared with 0.5% sodium caseinate in the 
external aqueous phase. Yields of multiple emulsions containing 
2% (w/v) SUPER GUM'" in the external aqueous phase 
displayed almost 10096 EE. However, under the present 
conditions, 2% SUPER GlJMT" was unable to fonn a stable 
multiple emulsion in terms of particle size. Higher 
concentration of SUPER GUM"" may be required in the 
external aqueous phase to achieve a more stable multiple 
emulsion. 
Under the current experimental conditions, the addition of 
inaeased concentration of SUPER GUM"'>< dissolved in sodium 
phosphate buffer did not significantly improve the yield and 
stability of multiple emulsions when it was added to the internal 
aqueous phase of multiple emulsions. It is unclear is this 
adverse effect is due to the presence of some insoluble material 
in the SUPER GUM"" material in sodiwn phosphate buffer. 
Subsequent work to this has shown that when SUPER GiJM'" 
was dissolved in distilled water, it had a positive effect on both 
the yield and stability of multiple emulsions when applied in 
either internal or external aqueous phase"l. 
3-3. Mkruenclpliwation of GIIn"OD 
As an indicalion of Glovon's anti-microbial activilY, S. aureus 
9518 was incubated with different concentrations of 
microencapsulated and non-encapsulated Glovon for up 10 &l 
mins. Glovon and microencapsulated Glovon (MEG) were 
tested at identical concentrations (025, 0.5 and 1.0%); however, 
it must be noted that the MEG contained n.7% GIovon, due 10 
the ~ce of the miaoencapsulation material. 
In general, MEG exhibited less anti-microbial activity than 
the non-encapsulated form (Figure 4). Following 10 mins 
incubation of 9518 with a I % solution of MEG, 9518 was 
undetectable (FIgUre 4b), whereas in less than 3 mins. 9518 was 
undetectable in the presence of 1% Glovon (FIgUre 4a). At 
lower concentrations of Glavan, a time dependant decrease in 
9518 was observed up to 60 mins, with 1.3 and 2.4 log 
reductions in the presence of 0.25 and 0.5% Glovon, 
respectively. After 60 ruins incubation, log reductions of 1.1 and 
2.2 were observed with the 0.25 and 0.5% MEG samples, 
respectiYely (FIgUre 4b), which was less than the log reduction 
noted fur the non-encapsulated Glavan (Figure 4a). However, 
the reduced activity of MEG compared to Glovoo was not as 
great as expected · if all of the active components of Glovon 
were fully microencapsulated, no activity would be expected. 
Thus, either there must be some breakdown in the 
microencapsulation system over time or all of the Glovon must 
not have been microencapsulated to start with. A further 
experiment was conducted to detennine the effect of hydration 
on Glavan and MEG on the ingredients consequent ability to 
reduce the viability of Staphylococcus aureus 951& 
Solutions of Glovon and MEG were hydrated in TSB for 1 
hour, and subsequently added to stock solutions of 
SlaphyJocoa:us aureus9518 (FIgUre 5). As observed previously. 
Glavan and MEG reduced the viability of StaphyJOCOCC11S 
aureus 9518 by 2.6 and 4.2 iogs, respecthoe}y. While hydration 
had little effect on Glovon, it did enhance the anti·microbial 
activity of MEG, inferring that the rniaoencapsulation coating 
was dissolving over time, and thus the active components of 
Glovon were free to act 
The effects of 5 and 7.5% bile salts on anti-microbial activity 
of 9518 were also determined to give an indication of Glovon 
activity upon entry into the small intestine (Figure 6) . The 
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Figure 4. Effect of incubation time on anU-microbial activity of 
dille rent concentrations 01 Glovon (a) lind 
rncroencap:sulated Glovon (MEG; b) against 5. atlreus 
9518. 
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presence of 5 and 7.5% bile salts alone had little effect 00 9518 
viability after- incubation for 60 mins (results not showc). While 
Glovon completely eliminated Staphylococcus lIuretJS 9518 after 
10 mins, increasing bile salts concentration dramatically 
reduced the ability of Glovon to reduce the viability of 
Staphylococcus aureus 9518 (F1i"UJ"e 6a). This indicated that the 
bile salts effectively romplex the active components of Gkwon, 
resulting in reduced anti·microbial activity. The anti-microbial 
activity of MEG, on the other hand, did not appear affected by 
the presence of 5% bile salts (Figure 6b) . However. the 
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FtgUfe 5. Effect Of incubation time on antHnicrobiaJ aCtiVity of 
Gtovon, microencapsulated Glovon (MEG) used 
Immediately or aftef hydration lor 1 hoor against S. 
aureus 9518. 
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Figure 6. Effect 01 Incuballon time on anti-microbial activity 01 
GIovon (a) and microencapsulated GIoYon (MEG; b) in 
the absence and presence 01 5 and 7.5% bile salts 
against S. aureus 9518. 
presence of 7.5% bile salts greatly reduced the activity of 
Glavan to a level s imilar to that observed in the non· 
encapsulated Glavan, also at 7.5% bile salts. A likely 
explanation of this effect is that the free Glovon in the MEG 
sample (which increases in concentration the longer the sample 
is hydrated) was immediately OOWld by the high level. of bile 
"'''-
A second series of experiments focussed on the activity of 
MEG and non-encapsulated Glovon in simulated gastric, ileum 
and colon juice against Lactococcus Jactis HP, Lactobacillus 
gassen' and Lactobacillus gasseri, respectively. Both MEG and 
non-encapsulated Glavan retained full activity against the 
pathogens tested (results not shown). This indicates that the 
active components of Glavan are available to act against 
pathogens in simulated gastrointestinal conditions. 
4. Conclusion 
SUPER GUM'" successfully a ided in the increased 
encapsulation efficiencies of multiple emulsions when 
incorporated into the external aquoous phase. However, the 
stabilities or encapsulation efficiencies of multiple emulsions 
were not improved on addition of SUPER GUM'" to the internal 
aqueous phase. This may be due to the partial insolubility of 
SUPER GUM'" in a sodium pbosphate buffer system. On the 
other hand, SUPER GUMnI successfully microencapsulated 
Glovon, resulting in decreased activity against S aureus 9518 
compared to non-encapsulated Glavan. In addition, 
microencapsulated Glovon retained greater activity against S 
aureus 9518 in the presence of bile salts, compared to non-
encapsu]ated GI0Y00. 
(B*HIR (JlIi)) 
Foods &. Food Ingredients J. Jpn .. Vol. 213. NO.3. 2006 
References 
1) E. Dldtinson. M. GoldinII' alld M. J. W PoYer. J . lAlloid InL Set .. 185. 
51~1997) 
2) C. V. Morr IJId E. YWHa. Crit. ~v. Food Set. Nutr .. 33. 431(1993) 
3) Y. R. x;., ancI N. S. Hettiarxbchy. J. Food Sci. 112. 1101 (l997) 
4) 1. F1anlj/a$l and II. S. f'lt:z(;.,r2id./nt Dairy f .. 12. 737(2002) 
SI A. Yeancl H. S/neh. Food Hyd..:zo. 269(2006). 
&) 1. Lerou>:. V w,;01I(\Orlf. G. Schick. V. VaiolUlav Mod J Muoyn'. Food 
HyU .. 17. 455(21m). 
1) L NiIuoQ and B. 8erien!Uhl.j. J!er"it'. FoodCbem.. ss. 14a9{2OO7). 
8) E. DlckiDoon. v. B. Galazka."d D. M. W. Allder$On. CN/xJhyd. f'olymer, 
14.373(1991) 
9) A.. Lamp~h(. U. F. Sc:hafer ancI C. M. LehT. Etor. j. Pfwm. ~ 4lJ. 
",.." 
10) ,\. K. Ray. P. B. BiN!. G. ,\. 1Icobucci Ind B. C. Clarl. Food Hyd .• •. 
123(1995) . 
II) Y. D. Kim IJId C. v. MorT.f. A,rrfc. Food ClmL.44. 1314(1996) 
12) S. AJ.AIsat. G. O. PIIinipe. H. Aoki IIId Y. SosUJ. Food H]'d., 21. 31!1(2OO'1}. 
13) H. Mki. S. Al-A55af. T. Katayama Ind G. O. Phililpa. FolXi Hyd .. 21. 
-. 14) N.A. Plcldea. H. "old,S. A/.AuaI, M. s.l<aI:o. T. aa-.--. H. E. ~Iaod. II. 
C. Coleman. G. O. Phillips and S. H. Wiliams. Food Hrd.. 21. 3l8(2OO7) 
15) S. W. Cui. G. O. Phillips. B. BlKtweU and 1. Nlkifi:>ruk. Food Hyd. 21. 347 
""'" 1(1) H. Aoki. T. K.ata)'llna. T. Oraawa .... Y. S. .. ki. S. Al-Aluf IDol G a 
PhillIps. Food Hyd .• 21, 353(2007). 
l1J lot. c:.o.meur. 101.. BIIneo-Prido. F. Puilietm. B. Roqueo aDd E. FItt3I. Adv. 
I.>rugDd.~ .. 28, 8:5(1997). 
IS) H. Okochi arid M. Noboo, Mv. DTV/l Del. &.0, 45. 5(200)). 
19) T. Hino. S. Slti ....... ruhi. M. Tonaka. N . Nakano o d H. Okochl. f . 
Microeoc::.p..1a. 19(2001). 
20) A BeniclxJu.A MeriDlII!d N. CriMv. Colloid lDl. Sci, 1011-109.29(2004). 
21) J.Su,S . F\anapD. Y Hemarll'ld H. SiO'Irh. Food HyrJ, 20, 261(2006) 
"A-/t-1ib." Q)V..(~[J1.J':11!/lIftli:d:.J>M1! 
JOhn Flanagan--'" Jiahong Suo> Coirn C'Srlent" Brid C'Riordan" Harlfnder Slnsh"' COIum Dunne" 
• R/ddet Centre, Masaey university 
Private Bag 11-222. Paimerston North. New Zealand 
• Glanbia Innovatlan Centre. Glarbla Nutritionale 
Lessetsrath Business Part. Carlow Road. Kllkemy. ireland 
7:1 ~7 jf J." 1.1.1:iJ.I::td.: ') -r1t.fHUU:: il ~ '-r JtIt.~.!;: L.-r 
flJmt!'h't'!t.: . lliiJ.. "<'-( :7o;tt-:f-l::JI..(t(/)t;:1fi1:77~7t1 
J,. H!tm-r g (aJff:'I!Q)) fJ!1I:nt .. ;;.. )lfi::tI9ttM' t- Mil, 't.'~, 
.g . ";J.. -J~- jf A" (I)£-r-li~t! n "(\I g &JR: 7 ., ~7 jf J,.nl. 
.i!i l:: ./i -) 't'$lIl:/i) t! ht.:. ~;J.. -I (- jf J,. ~ 1i:1JJlltraIt!I:: J;: 
'? 't'&JR: t: h -Cts I) , *&.(1)7., ~7 jf AI::.It~.g J:! ~H-.f:t 
iI* L.. fJiliilS'I!ff:M.ft t: n 't'p.g . *i3f'9i:I:t. ' ;J.. - , ( - 11 J,.' 
(/);tt -:f -l! Mt1t:a: .!;: I" ,,(, 2"?(I)"~ ? t.: 7 7" I) ~ - ~ , ;.t (15m) 
t-M1rL."(L)-li . ~ A -Jt- lIA ~ f.~IIU::JtftMG:I,."(flJmT 
.g .: G: I: J;: '? -c . .¥~t.I:""ft~o1);tt 7" -!::':)Ht~!4h)I~J:. L. t.: . 2'? 
EI 01)7 7" I) "T - ~ J / J:: I" "(ill1'lI: IIJJl t: ht:Wi.mUDlIJIIJ( 
oi.'t.'.b.g:),'O - :f,;.t(/)-.;o' -( :7 0 n 1'-I::)I,ftl::'?~ ,"( Mi@iL."(I) 
.g . 7'0 - m /11)"<' -( 17 0 JJ l' -!::': A-fti/1a-tf-0J!n- J:! P'{ Ii. of 
261 
nnllll-1f f- .. {; 't' .1!n.g~IH$l1)jIjI.jI: tII:h f- ~lt't.'! .g J;: 1 
,NIIM(/)M:iE:IllI7TI:i!t»)6Ii').g J;: 11:"tf> "k.'t)-r-I>.g o "<' -( 7 t1 
;tt -:f t;,n,ft ~ ht.: 7'0 _. m:;'- nl.@.'f It., ~ri95181:ii L.ffitt t-
m;'ft!-it6':J:!n1aJtt!n. :)'o - m:"-i/I,,<,-( :7p;lr1'-!::':A-ftt! 
n 't' ~,.g,: t "* I" t:. *.fOilflllll1)-II: ~ J:! Il.rtll.m¥t£ to 7' 0 
-,y,;.t td J; tf"<' -( 7 [J';tt -:f -!::,:)l..ft ~ Il -:f, /(/)tJtllf'l!m 1:~t.I: ., 
"k. ~.t-&~L. . "<'-(7on1'-I:: )l.. ft7"o - ,y,/~*7"t:)I,ftt! 
h "( pf,t ~ 17"0 - ;f.:"- J; t) Mfipi8ttt-M:»i'.g,: t f-jji.: L. t.:. 
(~6). 
, 
. "---~------------------~----­o '0 m ~ ~ ~ ~ ro 
..... t_) 
'" .~=== 
-~. 
-~, 
__ WEO • 5 .. !Ioo .... 
..... ..eo.7.S .. _ ..... 
. ~------------~~-­Q '0 ~ ~ ~ ~ ~ ro 
..... ( ...... ) 
1116. S. allf8(ls (.e.:1I'"t)fla) 9518I.:ML.. . -10-#:"- (.) 
/::, ""71'70b?'-t!/ld(:L..t.:-1c->tf:..- (b) tm~'. *.fIl 
1I0)1i#IIIHii L.. f!:.tI30)j;tIl~ft t •• 2i(:1'. L.. ""( ~ \~ 0 
PROFILE 
John Flanagan 
RIddM Centre. MuHy UnMrIity 
Gbnbll. Innov,,*,,", C.mre _ ... .. , 
..... ,. 
Or. Flanaoan complegd his doctorate 
studies In 2002 at the Unlvel'$lty of 
L.mtrick. nIin1, focuIIing on ~ 
the functional prop,rtl61 01 sodium 
casalnabl through the use 01 ~ 
modification. He then IICC8PIed • ttv"ea 
year post--clocllnl poaitIon at h AIddat 
eemr.. Massey ~, New ZMIatIc:I 
whe,.. hi' eKperience with emulaiol"l 
systems _ e~ Other areas of 
rese.rch. auch IS mlcroemulalons, 
mutipIe emulsions, ~ CO\/IIIent 
and l1OfHlO'o'aIent proteIn-polyaacehBrk:le 
imara:;tiona w«1I allIO develope4. Or. 
Flanagan subsequently Joined Glar1bla 
NutriIklrJaIa n ..u. 2006 to wtiIIIIt a ,.. 
microencapsulation platform for the 
"""'-
262 
FFI JOURNAl. Vol. 213. NO.3. 2008 
Jiahong Su 
Calm O'Brien 
Brid O'Riordan 
Harjinder Singh 
~ HIwjndIIf" Singh c:uo.-entIy holds 
a ChaIr n Oralry Science and Tectnology 
.MM&By~. He laalaoa oncu 
01 the Rlddet Institute (Ne..., Zealand 
CetICN 01 Research EKc.Iance n Foods 
and Blologlcala). Hla main ara" 01 
expertise IncIuda milk protein sIn.Icttn 
and~. bod arrlIIsiona and gel. 
and eneapaulatlon and delivery of 
bioactNa compounds. He has published 
over 200 papers in i,lei .. atic ..... jcK.mIiIs. 
and" 0.-. 01 lSI ~ cftIiId 'esen"t1Wn. 
He was cIectud Fellow of AoyIIl SocIIIy of 
N_ Zealand (2002) and Fellow 01 the 
Intematlonal Academy of Food SCience 
and Tadn*Igy (2OO6J. He _-.n;IBd 
Marschall Rhodia Int9matlonal Oairy 
Scienca Award (2001) by the AmIIfIcan 
Dairy SCIence Association, USA tor his 
contributions to the dairy protein 
1'M8I.I'Ch. He Is membaf of the !dtori!II 
boards 0110: lrolei , ........ pun-. 
Colum Dunne 
COIum Dunne (B.Sc.[Honsj,Ph.O •• MBN 
has held ~ as Managao" 01 
multi·cent,. cllnlcal trials focused on 
IntsstinaI health i!It In!I5lcf's NatiorIaI Food 
Biollllct.lologf CanIre; a.n.eI Manager 
of Ireland'a only ... ",reh centre 
dedicated solely to c.ncer research, 
where the teems became IocuIad on the 
propt"tfIactic .-.d ~ poIIeI"IIIiII of 
functional fooda, In addition to the 
emergirIg -., 01' rnedlcaI omcea and 
conb'Olkid gene thefapy. Mo$t recently. 
CoIu'n joined G'-'bia. NutriIIr:InaIs where 
lie ia now Rasearch and Developme-nt 
0Ir9ct0r. Cokm hal. published nxn then 
50 scientific IirtlI::lM and patents. He is 
cumtnUy guest executlYII aditor of Ihe 
jCuneI Q.-rent PhII,,1I!IOOUIk:aI Design. 
